Related references
Note: Only part of the references are listed.Proton MRS in twin pairs discordant for schizophrenia
E. S. Lutkenhoff et al.
MOLECULAR PSYCHIATRY (2010)
1H-MRS at 4 Tesla in minimally treated early schizophrenia
J. R. Bustillo et al.
MOLECULAR PSYCHIATRY (2010)
Differential Expression of Metabotropic Glutamate Receptors 2 and 3 in Schizophrenia: A Mechanism for Antipsychotic Drug Action?
Subroto Ghose et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR
Anne-Cecile Fricker et al.
NEUROPHARMACOLOGY (2009)
Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS)
Shin'Ya Tayoshi et al.
SCHIZOPHRENIA RESEARCH (2009)
Common Neural Circuitry Supporting Volitional Saccades and Its Disruption in Schizophrenia Patients and Relatives
Jazmin Camchong et al.
BIOLOGICAL PSYCHIATRY (2008)
Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors
Rafal T. Olszewski et al.
BIOLOGICAL PSYCHIATRY (2008)
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
Rodrigo D. Paz et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells
Peethambaran Arun et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Dysregulation of glutamate carboxypeptidase II in psychiatric disease
Tomas R. Guilarte et al.
SCHIZOPHRENIA RESEARCH (2008)
Frontolimbic glutamate alterations in first episode schizophrenia: Evidence from a magnetic resonance spectroscopy study
Hans M. Olbrich et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla
Richard A. E. Edden et al.
MAGNETIC RESONANCE IN MEDICINE (2007)
N-acetylaspartate in the CNS:: From neurodiagnostics to neurobiology
John R. Moffett et al.
PROGRESS IN NEUROBIOLOGY (2007)
Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia
Frank Jessen et al.
SCHIZOPHRENIA RESEARCH (2006)
NAAG peptidase inhibitors and their potential for diagnosis and therapy
J Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with review and meta-analysis
RG Steen et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Selective impairment of attentional networks of orienting and executive control in schizophrenia
K Wang et al.
SCHIZOPHRENIA RESEARCH (2005)
Time-domain semi-parametric estimation based on a metabolite basis set
H Ratiney et al.
NMR IN BIOMEDICINE (2005)
Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain
JW Pan et al.
ANNALS OF NEUROLOGY (2005)
1H metabolite relaxation times at 3.0 tesla:: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation
F Träber et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2004)
NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR
RT Olszewski et al.
JOURNAL OF NEUROCHEMISTRY (2004)
N-acetylaspartate and N-acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: A postmortem study
S Nudmamud et al.
BIOLOGICAL PSYCHIATRY (2003)
Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS
J Theberge et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Java-based graphical user interface for the MRUI quantitation package
A Naressi et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2001)